Irradiation of salivary glands during radiotherapy treatment of patients with head and neck cancer evokes persistent hyposalivation. This results from depletion of stem cells, which renders the gland incapable of replenishing saliva to produce acinar cells. The aim of this study was to investigate whether it is possible to expand the salivary gland stem/ progenitor cell population, thereby preventing acinar cell depletion and subsequent gland dysfunction after irradiation. To induce cell proliferation, keratinocyte growth factor (⌬N23-KGF, palifermin) was administered to C57BL/6 mice for 4 days before and/or after local irradiation of salivary glands. Salivary gland vitality was quantified by in vivo saliva flow rates, morphological measurements, and a newly developed in vitro salisphere progenitor/stem cell assay. Irradiation of salivary glands led to a pronounced reduction in the stem cells of the tissues, resulting in severe hyposalivation and a reduced number of acinar cells. ⌬N23-KGF treatment for 4 days before irradiation indeed induced salivary gland stem/progenitor cell proliferation, increasing the stem and progenitor cell pool. This did not change the relative radiation sensitivity of the stem/progenitor cells, but, as a consequence, an absolute higher number of stem/ progenitor cells and acinar cells survived after radiation. Postirradiation treatment with ⌬N23-KGF also improved gland function, and this effect was much more pronounced in ⌬N23-KGF pretreated animals. Post-treatment with ⌬N23-KGF seemed to act through accelerated expansion of the pool of progenitor/stem cells that survived the irradiation treatment. Overall, our data indicate that ⌬N23-KGF is a promising drug to enhance the number of salivary gland progenitor/stem cells and consequently prevent radiationinduced hyposalivation.
INTRODUCTION
Yearly, head and neck cancer is newly diagnosed in more than 45,000 patients worldwide [1] . Radiotherapy, either alone or in combination with surgery and chemotherapy, is often applied as a treatment for these patients. The radiation dose by which the tumor can be treated is limited by the sensitivity of surrounding normal tissues within the field of radiation. For head and neck cancers, even with the most optimal radiation schedule, salivary glands are tissues at risk. Progressive loss of function may occur within the first weeks of radiotherapy and can persist for life [2] . Radiation-induced salivary gland dysfunction may cause oral dryness, dental caries, hampered speech, and xerostomia (dry mouth syndrome), which collectively severely limit the quality of life of the patients [3, 4] .
The delayed loss of gland function after radiation is thought to be due to a loss of stem cells that are no longer able to replenish aged saliva-producing acinar cells [5] . In normal salivary glands, the ductal system that includes excretory, striated, and intercalated ducts biochemically modifies and transports saliva, produced by acinar cells, into the oral cavity. This ductal system also contains the tissue stem/progenitor cells [6 -8] . Proliferation and differentiation of these primitive cells within the ducts maintains homeostasis of the acinar cells. Expansion of the salivary gland stem/progenitor cell population may prevent acinar cell depletion and subsequent gland dysfunction after radiation. In line with this, transplantation of the tissue stem cells induced regeneration of irradiated salivary glands [7] .
Although the effect of keratinocyte growth factor (⌬N23-KGF, fibroblast growth factor-7 [FGF]-7, palifermin) on the salivary gland has not been studied, ⌬N23-KGF has been shown to ameliorate radiation-induced damage in a variety of other tissues, such as lung [9 -12] , gut [13, 14] , tongue [15] , and oral mucosa [16] . The mechanism is believed to result from either stimulation of proliferation [14, [17] [18] [19] [20] [21] , direct radioprotection [22] , and/or stimulation of cell motility [23] .
In this study, several ⌬N23-KGF treatment schedules were evaluated for their efficacy to reduce salivary gland morphology and function after irradiation in mice. In addition, effects were evaluated using a recently developed in vitro salivary gland stem/progenitor assay [7] . It was found that ⌬N23-KGF administration before and after irradiation of salivary glands induced a long-term expansion of duct stem/progenitor cells, which elicited short-and long-term maintenance of the acinar cell compartment, resulting in permanent preservation of the salivary gland function after irradiation.
MATERIALS AND METHODS

Animals
Female C57BL/6 mice, 8 -12 weeks old, were purchased from Harlan (Horst, The Netherlands, NL, http://www.harlaneurope. com). The mice were kept under clean conventional conditions and fed ad libitum with food pellets (RMH-B; Hope Farms B.V., Woerden, The Netherlands, http://www.hopefarms.nl) and acidified tap water (pH ϭ 2.8). All experiments were approved by the ethics committee on animal testing of the University of Groningen.
Irradiation of the Salivary Glands
Salivary glands were locally irradiated with a single dose of 10, 12.5, 15, 17.5, or 20 Gy of radiation (CMG 41 X, 200 kV, 10 mA, 5 Gy/min; Philips, Eindhoven, The Netherlands, http://www. philips.nl). Mice were protected from off-target radiation by a lead shield. These radiation doses are known to induce sufficient damage without compromising the general health of the animals.
⌬N23-KGF and 5-Bromo-2-Deoxyuridine Administration
⌬N23-KGF (5 mg/kg per day, Amgen, Thousand Oaks, CA, http:// www.amgen.com), the recombinantly produced form of KGF in which the first 23 amino acids of the amino terminus have been deleted from the mature KGF, was used because of its increased stability and was administered s.c. before or/and directly after irradiation according to the scheme in Figure 1 . Unirradiated mice received ⌬N23-KGF for 4 or 7 consecutive days.
To determine the effect of ⌬N23-KGF on cell proliferation, 5-bromo-2Ј-deoxyuridine (BrdU) (50 mg/kg i.p.) was administered together with ⌬N23-KGF treatment, when appropriate. Twenty-four hours after the last ⌬N23-KGF/BrdU injection, mice were sacrificed, and glands were collected for further investigation.
Saliva Collection
At 30, 60, and 90 days after irradiation the saliva flow rate was determined. Animals were placed in a restraining device [24] , and saliva was collected for 15 minutes after pilocarpine injection (2 mg/kg s.c.). The saliva volume was determined gravimetrically, assuming a density of 1 g/ml for saliva.
Immunohistochemical Processing
After extirpation, the submandibular glands were weighed and incubated for 30 hours at 4°C in 4% buffered formaldehyde. After dehydration, the tissue was embedded in paraffin. Sections (5 m) were analyzed for acinar cells using periodic acid-Schiff's base (PAS) staining. Ductal cells were identified using an anti-CK7 (MON3007; Monosan, Burlingame, CA, http://www.monosan.com) antibody, the receptor for KGF was detected using an antiFGFR2IIIbantibody (MAB7161; R&D Systems, Minneapolis, http://www.rndsystems.com) after a trypsin pretreatment, and proliferation was assessed by BrdU presence using anti-BrdU antibodies (ab6326; Abcam, Cambridge, U.K., http://www.abcam.com) (1:500 1 hour) after citrate treatment. Secondary anti-rat biotin antibodies (Elite ABC-kit; Vector Laboratories, Burlingame, CA, http://www.vectorlabs.com) and diaminobenzidine were used to detect the expression. In addition, nuclear staining was performed (hematoxylin).
Quantification of Acinar and Ductal Cells in Salivary Glands
Tissue sections of submandibular glands were analyzed using bright-field microscopy (CX40; Olympus, Hamburg, Germany, http://www.olympus-global.com) under ϫ400 magnification, with evaluation of 100 squares of 0.25 mm 2 each. The percentage of surface area occupied by acinar cells was counted from two different sections (upper middle) of each submandibular gland.
The different duct compartments (excretory, striated, and intercalated duct cells) were quantified by using the analySIS program (Olympus Soft Imaging System; Olympus, Münster, Germany, http://www.olympus-global.com) by measuring the area occupied by the different duct compartments. In further data processing, the percentage of the surface area of the ducts and acinar cells per gland was calculated.
Determination of Stem/Progenitor Cell Number
Submandibular glands were extirpated and processed for cell isolation as described previously [7] . Salivary gland cells were plated in a defined medium of Dulbecco's modified Eagle's medium's medium/Ham's F-12 (catalog nos. 41966-029 and 21765-029, respectively; Gibco, Carlsbad, CA, http://www.invitrogen.com), penicillin, streptomycin, GlutaMAX, epidermal growth factor (20 ng/ml), FGF-2 (20 ng/ml), N2 (1/100), insulin (10 g/ml), and dexamethasone (1 M) [25] . All growth factors were purchased from Sigma-Aldrich (St. Louis, http://www.sigmaaldrich.com), except for N 2 (Gibco). After 3 days of culture, spheres were counted and recalculated as a percentage per plated cells.
For flow cytometric analysis of c-Kit ϩ cells, salispheres were dissociated by 0.05% trypsin-EDTA (catalog no. 25300; Gibco) with mechanical use of 26-gauge needles. Cells were incubated for 20 minutes. with anti-c-Kit fluorescein isothiocyanate (catalog no. 553354; BD Biosciences Pharmingen, San Diego, http://www.bdbiosciences.com/index_us.shtml) antibodies at 4°C. Cells were analyzed on a FACSCalibur Flow Cytometer (Becton, Dickinson and Company, Franklin Lakes, NJ, http://www.bd.com) after the addition of propidium iodide (2 g/ml) to select for living cells. For each measurement a minimum of 100,000 events were collected. Data were analyzed 
Salispheres Are Responsive to ⌬N23-KGF
Three-day-old untreated salispheres were stimulated with KGF (100 ng/ml) and collected 10, 30, or 60 minutes hereafter. The spheres were treated on ice with lysis buffer (50 mM Tris-HCl [pH 7.4], 5 mM EDTA, 250 mM NaCl, and 0.1% Triton X-100) supplemented with protease inhibitors (catalog no. 1697498; Roche Diagnostics, Laval, QC, Canada, http://www.roche-applied-science. com) and phosphatase inhibitors (1 mM phenylmethylsulfonyl fluoride, 25 mM Na 3 VO 4 , and 0.5 M NaF). After the protein concentration was determined by the Bradford assay, the extracts were subjected to SDS-polyacrylamide gel electrophoresis, and proteins were electrotransferred to nitrocellulose membranes. Immunodetection was performed using ECL WB substrate (catalog no. 32106; Pierce, Rockford, IL, http://www.piercenet.com) and antibodies against mitogen-activated protein kinase (MAPK) (M5780; Sigma-Aldrich), FGFR2IIIb (MAB7161; R&D Systems), and ␥-tubulin (T6557; Sigma-Aldrich).
Statistical Analysis
The results were analyzed using a Mann-Whitney test or Student's t test. Statistical significance was defined as p Ͻ .05 using SPSS (SPSS, Chicago, IL, http://www.spss.com). Numbers represent mean Ϯ SEM.
RESULTS
⌬N23-KGF Prevents Radiation-Induced Salivary Gland Dysfunction
To investigate whether administration of ⌬N23-KGF could reduce radiation toxicity to salivary glands, mice receiving local salivary gland irradiation (IR) (15 Gy) were treated with ⌬N23-KGF either four times before (K-IR) or after irradiation (IR-K) or for a 7-day schedule with irradiation in the middle of the treatment (K-IR-K) (Fig. 1) . As control groups, mice that were only irradiated and mice that received only ⌬N23-KGF were included. Salivary gland function measurements (30, 60 , and 90 days after irradiation) showed that saliva production in nonirradiated mice that were treated with ⌬N23-KGF for 4 or 7 days was not significantly different from that in untreated animals ( Fig. 2A) albeit with some gland hypertrophy as indicated by an increase in wet weight of the submandibular glands (supplemental online Fig. 1 ). As expected, irradiated mice that did not receive ⌬N23-KGF developed severe hyposalivation ( Fig. 2A) . In contrast, ⌬N23-KGF treatment, irrespective of the treatment schedule, resulted in significantly more saliva production in irradiated mice than in nontreated animals. ⌬N23-KGF treatment before radiation resulted in a delayed onset of radiationinduced reduction in saliva flow rate, whereas ⌬N23-KGF treatment after radiation was least effective. However, when ⌬N23-KGF was administered both before and after radiation, saliva production was best preserved (Fig. 2A) . To establish potential dose dependence of a K-IR-K treatment, saliva flow rate was measured at 30 days after graded doses of irradiation (Fig. 2B) . Indeed, a dose-dependent reduction in flow rate was observed, however, with a virtually identical slope as that for irradiation alone, indicating that the effect of ⌬N23-KGF treatment before and after irradiation is not radiation dose-dependent.
Significantly higher wet submandibular gland weights were observed 3 months after 4 or 7 days of ⌬N23-KGF treatment, compared with those in untreated animals (supplemental online Fig. 1 ). Ninety days after irradiation, submandibular gland weight decreased to 58% of that in untreated controls. In agreement with the flow rate data, all ⌬N23-KGF treatment schedules had significant beneficial effects on submandibular gland weight and gland weight correlated with saliva production, suggesting that ⌬N23-KGF exerts protective effects before and after irradiation.
Trophic Effect of ⌬N23-KGF on Acinar Cells
To investigate which cells are responsible for the protective effect of ⌬N23-KGF, submandibular glands from ⌬N23-KGFtreated irradiated and nonirradiated mice were examined (Fig.  3) . A normal salivary gland consists of approximately 60% of PAS ϩ mucin-containing acinar cells grouped in acini (Fig. 3A , purple cells, arrows) connected to the ductal compartment (Fig.  3A , blue cells, arrowheads) comprising three different cell types; intercalated, striated, and excretory duct cells which are collectively responsible for the modification and transport of the saliva produced by the acinar cells [26] .
⌬N23-KGF treatment for 4 or 7 days caused a rapid (24 hours after the last injection), but modest, increase in acinar cell surface area (10%) (data not shown), which almost normalized in time (90 days post-treatment) (Fig. 3B, 3G ). Massive acinar cell depletion (Fig. 3C, arrows, 3G ) and fibrotic cell deposition (Fig. 3C, asterisks) , hallmarks of late irradiation damage, were clearly visible 90 days after irradiation. In contrast, post-irradiation treatment with ⌬N23-KGF (Fig. 3D, 3G ) reduced acinar cell loss, whereas pretreatment largely (Fig. 3E, 3G ) and preplus post-treatment (Fig. 3F, 3G ) almost completely abrogated the net loss of acinar cells.
⌬N23-KGF Enhances Stem/Progenitor Cell Numbers
To assess whether the protective effect of ⌬N23-KGF is due to a proliferative effect on acinar cells, in vivo BrdU incorporation in submandibular glands from animals treated with ⌬N23-KGF for 4 days was investigated. Whereas glands from normal mice hardly showed any proliferating cells, large numbers of BrdU ϩ acinar cells were observed in salivary glands of ⌬N23-KGF-treated animals 24 hours after the last treatment (Fig. 4A) . Similar effects of ⌬N23-KGF on the proliferation of oral mucosa were shown before by Borges et al. [18] . Additionally, BrdU incorporation was clearly present in intercalated (arrowheads) and excretory duct cells (arrows), indicating that these cell types also were stimulated to proliferate. Remarkably, however, the receptor for ⌬N23-KGF, FGFR2IIIb, was exclusively expressed on intercalated (Fig. 4B, arrowheads) and excretory duct cells (Fig. 4B,  arrows) and not on acinar cells. In addition to the 10% increase in acinar cells noticed after 24 hours in the 4-day KGF-treated mice, this implies that the increase in proliferation of acinar cells probably originated from a direct stimulatory effect of ⌬N23-KGF on intercalated and/or excretory duct cells that subsequently differentiate into acinar cells. To test this, the surface area occupied by these different ductal cell types, as a reflection of cell number, was evaluated after a 4-day exposure to ⌬N23-KGF. Twenty-four hours after the last ⌬N23-KGF injection, an increase in surface area of excretory (2.8-fold) and intercalated duct cells (1.8-fold) in these glands was observed (Fig. 4C) , reflecting their high proliferation rate. After 90 days the surface area occupied by excretory duct cells remained somewhat elevated, whereas that of other cell types was back to baseline values. The transient enhancement of the number of intercalated and excretory duct cells in particular shortly after treatment indeed indicates that the increase in proliferation of acinar cells originates from dividing and subsequently differentiating intercalated duct cells. It also suggests that ⌬N23-KGF might expand the number of stem/progenitor cells known to reside in the ducts [6] .
To further substantiate the idea of expanding the pool of stem/progenitor cells, we cultured (sali)-spheres from salivary gland stem/progenitor cells [7] , similar to mammospheres [27] and neurospheres [28] . These spheres clearly expressed the KGF receptor (KGFR/FGFR2IIIb) (supplemental online Fig. 2A ) and responded to KGF treatment with phosphorylation of MAPKs (supplemental online Fig. 2B ). Interestingly, significantly more salispheres were formed from submandibular glands of mice treated with ⌬N23-KGF for 4 days compared with untreated animals (Fig. 4D , Normal vs. 4D K), demonstrating that KGF indeed induced the expansion of salivary gland salisphere-forming cells. As expected, irradiation (15 Gy) resulted in a pronounced reduction in the number of salispheres formed in culture (Fig. 4D,  IR) . In the ⌬N23-KGF pretreated animals, the remaining number of salisphere-forming cells that were recovered from the glands after 15 Gy was far higher and almost equal to the number recovered from glands from untreated controls (Fig.  4D, K-IR) . Salipheres cultured from untreated animals contained ϳ5% c-Kit ϩ cells, a percentage that did not change after IR and/or any of the ⌬N23-KGF treatments (data not shown). This finding indicates that ⌬N23-KGF treatment results in a net increase in salivary gland stem/progenitor cells (expansion), and thus the absolute number or remaining salisphere-forming cells after radiation is increased.
However, it has also been suggested that ⌬N23-KGF may be radioprotective for certain types of cells [22, 29 -31] , which would imply that the relative loss of salivary gland stem/progenitor cells also may be reduced after ⌬N23-KGF pretreatment. In fact, our 15-Gy data (Fig. 4D) indeed suggested that the relative loss of salisphere-forming cells may be reduced after ⌬N23-KGF pretreatment. To test whether this effect is indeed significant, glands of mice treated with ⌬N23-KGF were subsequently irradiated with graded doses (10, 12.5, 15, 17.5, and 20 Gy), and the number of salispheres that were formed in vitro 24 hours after the last ⌬N23-KGF injection was calculated (Fig. 4E) . Indeed, a dose-dependent decrease in salisphere-forming cells was observed. At all doses, the number of salispheres from irradiated glands was significantly higher after ⌬N23-KGF-treatment than after irradiation alone. However, the relative radiation-induced decrease in sphere formation after an ⌬N23-KGF pretreatment was equal over all doses, and the slopes of these curves were virtually the same (Fig. 4E) . This result suggests that ⌬N23-KGF has no effect on the intrinsic radiosensitivity of these primitive cells.
Taken together, these data show that ⌬N23-KGF increases resistance of salivary glands to irradiation by increasing the endogenous stem cell compartment, resulting in larger absolute number of surviving stem cells after irradiation.
Postirradiation ⌬N23-KGF Treatment Expands the Number of Radiation-Surviving Stem Cells
If the protection of ⌬N23-KGF pretreatment is due to an increment in the pool of progenitor/stem cells, the question The number of salispheres formed in culture from glands of normal, 4D K, IR, and K-IR treated mice sacrificed on day 4 showed that significantly more salispheres were detected after ⌬N23-KGF treatment compared with the numbers for untreated groups. (E): Salispheres were counted from IR and K-IR treated mice that received different radiation doses. Significantly more salispheres were recovered from glands in the K-IR group compared with the IR group. However, the irradiation dose-response curve (slope) was not altered by KGF. For all data in (C-E) a minimum of three mice were used. *, p Ͻ .05. Error bars represent SEM. Scale bar ϭ 50 m; inset ϭ 20 m. Abbreviations: 4D K, treatment with ⌬N23-KGF for 4 days; 7D K, treatment with ⌬N23-KGF for 7 days; IR, irradiation; IR-K, ⌬N23-KGF after irradiation; K-IR, ⌬N23-KGF before irradiation; K-IR-K, irradiation in the middle of ⌬N23-KGF treatment; KGF, keratinocyte growth factor. arises as to why the post-treatment with ⌬N23-KGF enhances gland recovery, especially in glands that were also pretreated with ⌬N23-KGF (Figs. 2, 3 ). To selectively investigate the effects of postradiation ⌬N23-KGF, we analyzed the glands of animals 24 hours after the last injection for proliferative cells using BrdU labeling. In glands that were irradiated without ⌬N23-KGF, BrdU ϩ cells were totally absent (not shown), but post-treatment with ⌬N23-KGF revealed BrdU ϩ cells in intercalated (Fig. 5A ) and excretory duct cells (not in figure) . In parallel, the surface area of these duct cells was higher at 10 days and even at 90 days after irradiation for the animals post-treated with ⌬N23-KGF (Fig. 5B ). In agreement with this finding, a post-irradiation ⌬N23-KGF treatment induced almost a doubling in the number of salispheres that could be isolated from glands 4 days after irradiation compared to untreated glands (Fig. 5C) . Similar, albeit more pronounced, results were obtained after a ⌬N23-KGF preand post-irradiation treatment schedule (data not shown). To summarize, whereas ⌬N23-KGF pretreatment enhances absolute salivary gland cell numbers before radiation, posttreatment accelerates the expansion of these surviving progenitor/stem cell pools. The latter effect is obviously more pronounced when there are more remaining progenitor/stem cells, explaining why post-treatment with ⌬N23-KGF is specifically effective in sparing gland function in ⌬N23-KGFpretreated animals.
DISCUSSION
This study demonstrates that expansion and activation of stem/progenitor cells by administration of ⌬N23-KGF before and after irradiation of the salivary glands yielded an almost normal saliva secretion and long-term preservation of all submandibular gland cell types. Several studies have suggested that KGF can increase the radioresistance of epithelial cells by enhancing DNA repair [22] , by altering expression of mediators or antagonists of apoptosis [32] , or by altering the ability of cells to scavenge free radicals [29 -31] . On the other hand, forcing cells into the cell cycle may make them more susceptible to irradiation. However, we were unable to detect any change in radiosensitivity by ⌬N23-KGF using our ex vivo salisphere assay. Instead, we suggest that the expansion of the stem cell pool appears to be mainly responsible for the observed amelioration of radiation-induced damage to the submandibular gland. We showed that pretreatment with ⌬N23-KGF increases the number of progenitor/stem cells, leading to a higher absolute number after radiation. Post-treatment ⌬N23-KGF can accelerate the proliferation/ expansion of the fraction of progenitor/stem cells that survived the radiation and hence further stimulate the effect of pretreatment ⌬N23-KGF.
⌬N23-KGF enhanced BrdU labeling in cells of acinar and duct compartments of the submandibular gland, which suggested that all cell types are proliferating. However, acinar cells do not express the FGFR2IIIb receptor and are therefore not likely to be stimulated by ⌬N23-KGF. Differentiation from intercalated duct cells into acinar cells has been shown to occur in submandibular glands of mice [6] , rats [8, 33] , and humans [34] . Therefore, the labeling and enhanced number of BrdU ϩ acinar cells is probably caused by proliferation and subsequent differentiation of intercalated duct cells. After ⌬N23-KGF stimulation, excretory and intercalated duct cells, both of which do express the ⌬N23-KGF receptors, rapidly increased in number, resulting in elongation of excretory ducts. Interestingly, during normal aging these ducts decrease in length [6] . The current study shows that after irradiation the number of salivary gland stem/progenitor cells surviving irradiation can be doubled by a pretreatment with ⌬N23-KGF.
The capacity of surviving stem/progenitor cells to (partly) repopulate the gland after stimulation with ⌬N23-KGF provides an interesting opportunity for novel targeted therapy. For future clinical use, a potential issue of concern is the possibility that ⌬N23-KGF may stimulate tumor proliferation. However, malignant hematopoietic cells, for example, are unresponsive to ⌬N23-KGF [35] and, strikingly, ⌬N23-KGF is now used in phase III trials to prevent chemo/ radiotherapy-induced oral mucositis in patients with hematopoietic malignancies [35] . Furthermore, head and neck squamous carcinoma cell lines expressing FGFR2IIIb receptors did not show an in vitro growth advantage or alteration in radiation sensitivity relative to normal nasal epithelial cells upon ⌬N23-KGF stimulation [36, 37] . This finding indicate that therapeutically effective doses of ⌬N23-KGF may not stimulate head and neck tumor cell growth. However, this issue needs to be further explored carefully. Other membrane receptorstimulating agents that ameliorate salivary gland damage after irradiation such as the muscarinic agonist pilocarpine [38] have been suggested to enhance postirradiation proliferation [39] . However, KGF is by far the most effective but only when administered both before and after irradiation.
Our study provides the first evidence that in vivo induction of expansion and differentiation of stem/progenitor cells by ⌬N23-KGF protects salivary glands against radiation damage. Hence, ⌬N23-KGF is a promising therapeutic modality to prevent radiation-induced gland dysfunction in patients with head and neck cancer.
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